The collaboration will validate the prognostic value of the NLRP3 biomarker, measured through ASC-specks using VIVA-ELISA® technology
Read moreSafety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational next-generation CD19-directed CAR-T cell therapy that is manufactured in 48 hours using...
Read moreLa Comunidad de Madrid ha detectado las causas que explican la persistencia de síntomas en celiacos pese a que sigan una dieta sin gluten. Un equipo de investigadores liderados por el Instituto Madri...
Read moreThe new study shows that pericytes do not disappear, instead, they are reprogrammed. This dysfunction is regulated by a cytokine (a secreted protein) called TGF-β, which acts as a messenger between t...
Read moreProfessionals from Hospital Clínic-IDIBAPS are leading two projects in medical technology innovation and two in advanced drug and therapy development, which have received funding through the Strategi...
Read moreUn nuevo protocolo sin quimioterapia logra injertos más seguros y eficaces en modelos de inmunodeficiencia y anemia por deficiencia de piruvato quinasa
Read moreEl TGF-beta juega un papel fundamental en el inicio y progresión del hepatocarcinoma, y la inhibición de su acción podría presentar un interés terapéutico. Sin embargo, su actividad es compleja ...
Read moreThe aim of the study is to identify 30 highly sensitized patients, who will undergo a leukapheresis, a process that allows white blood cells to be separated and extracted from a patient's blood. From ...
Read moreThe results confirm that combining durvalumab with FLOT (fluorouracilo, leucovorina, oxaliplatina y docetaxel) is not only effective but also safe for patients.
Read moreInvestigadores del CNB-CSIC han descubierto que los niveles de colesterol en la membrana celular afectan a la capacidad de las células inmunitarias para migrar a los tejidos donde son necesarias
Read moreEl Cancer Center Clínica Universidad de Navarra ha reunido a expertos nacionales en la II Jornada de Inmunoterapia del Cáncer Hepático para analizar los avances más prometedores en vacunas, terapi...
Read moreA CNIC study reveals that neutrophils—a type of immune cell—are less aggressive at night, explaining why nighttime heart attacks are less severe than those occurring during the day
Read more